Are histomorphological patterns a predictor for survival in uveal melanoma patients with hepatic metastases undergoing hepatic artery infusion chemotherapy?

J Med Imaging Radiat Oncol. 2024 Oct;68(7):862-869. doi: 10.1111/1754-9485.13783. Epub 2024 Sep 24.

Abstract

Introduction: In uveal melanoma (UM) patients with hepatic metastases, hepatic artery infusion chemotherapy (HAIC) is a viable, palliative treatment option. To evaluate the impact of two histomorphological patterns (spindle cell vs. epithelioid) of liver metastases on median overall survival (mOS) in UM patients undergoing HAIC.

Methods: A retrospective analysis with 60 UM patients (29 females, mean age: 61.6 ± 12.1 years) with hepatic metastases was performed. Histomorphological patterns in metastases were analysed and classified as either predominant spindle cell or epithelioid pattern. mOS between both patient groups was analysed using Kaplan-Meier curves and the log-rank test.

Results: In 73.3% (44/60) of the metastases, a predominant epithelioid pattern, in 21.7% (13/60) a predominant spindle cell pattern, and in 5% (3/60) other patterns were found. No significant differences between patients with an epithelioid (mOS: 14.2 months, 95% CI: 8.8-19.6) and a spindle cell pattern (mOS: 14.4 months, 95% CI: 4.3-24.5) were detected by the log-rank test, χ2(2) = 0.22, P = 0.881.

Conclusion: Histomorphological patterns of UM metastases do not seem to be a predictor for mOS in UM patients undergoing HAIC.

Keywords: HAIC; hepatic artery infusion therapy; histomorphological pattern; prognosis; survival.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Female
  • Hepatic Artery*
  • Humans
  • Infusions, Intra-Arterial*
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / secondary
  • Male
  • Melanoma* / drug therapy
  • Melanoma* / mortality
  • Melanoma* / pathology
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Survival Rate
  • Treatment Outcome
  • Uveal Neoplasms* / drug therapy
  • Uveal Neoplasms* / mortality
  • Uveal Neoplasms* / pathology

Substances

  • Antineoplastic Agents

Supplementary concepts

  • Uveal melanoma